Therapeutic Developments Targeting Toll-like Receptor-4-Mediated Neuroinflammation - Wikidata - awgldk - TriplyDB

Therapeutic Developments Targeting Toll-like Receptor-4-Mediated Neuroinflammation

Therapeutic Developments Targeting Toll-like Receptor-4-Mediated Neuroinflammation

http://www.wikidata.org/entity/Q35681383

about

Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment.Small-Molecule Carbohydrate-Based Immunostimulants.Peripheral immune tolerance alleviates the intracranial lipopolysaccharide injection-induced neuroinflammation and protects the dopaminergic neurons from neuroinflammation-related neurotoxicity.Rolipram, a Selective Phosphodiesterase 4 Inhibitor, Ameliorates Mechanical Hyperalgesia in a Rat Model of Chemotherapy-Induced Neuropathic Pain through Inhibition of Inflammatory Cytokines in the Dorsal Root Ganglion.Aromatic-Turmerone Attenuates LPS-Induced Neuroinflammation and Consequent Memory Impairment by Targeting TLR4-Dependent Signaling Pathway.Peripheral Blood Monocyte Tolerance Alleviates Intraperitoneal Lipopolysaccharides-Induced Neuroinflammation in Rats Via Upregulating the CD200R Expression.Toll-like receptor 4 modulation influences human neural stem cell proliferation and differentiation.Phenolic 1,3-diketones attenuate lipopolysaccharide-induced inflammatory response by an alternative magnesium-mediated mechanism.Toll-like receptor 4 ablation rescues against paraquat-triggered myocardial dysfunction: Role of ER stress and apoptosis.

P2860

Q37310533-74FD49E8-934E-4BD8-B037-8F8D93ADCE84 Q38844616-F3BDEA02-9818-4642-9A46-225341DEB06E Q45814315-09C2215D-1DBE-4C74-A3A5-C5234F35E4E9 Q47136755-60240F34-2686-4FD7-AD70-D939DA4659EF Q47744530-76E18F36-FE49-4CCE-83F6-F0326F7BFA03 Q48218418-89CC6708-5DF4-479F-9755-8F6C32D9477E Q49958576-18B939C9-2436-442D-AE91-3A952D9F98CE Q51137523-139C067B-9A30-42C3-8E65-EA3E56B5D450 Q51626575-DC9B6DC7-B6D5-4DFE-A5AD-1CC08D4B97F4

P2860

Therapeutic Developments Targeting Toll-like Receptor-4-Mediated Neuroinflammation

http://www.wikidata.org/entity/Q35681383

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Therapeutic Developments Targeting Toll-like Receptor-4-Mediated Neuroinflammation

@ast

Therapeutic Developments Targeting Toll-like Receptor-4-Mediated Neuroinflammation

@en

type

label

Therapeutic Developments Targeting Toll-like Receptor-4-Mediated Neuroinflammation

@ast

Therapeutic Developments Targeting Toll-like Receptor-4-Mediated Neuroinflammation

@en

prefLabel

Therapeutic Developments Targeting Toll-like Receptor-4-Mediated Neuroinflammation

@ast

Therapeutic Developments Targeting Toll-like Receptor-4-Mediated Neuroinflammation

@en

P1433

Q35681383-EAF2942D-3253-46FE-9C84-88C86A3EB74B

P1476

Q35681383-3E6AF414-EC84-4162-808C-F439BCB358F4

P2093

Q35681383-3133CCF7-AC6A-41EF-BE87-5EBFBD8D1BE0

Q35681383-3236E485-9288-4BA9-8D39-5A4B386CC6F7

Q35681383-C3441546-6A99-4D83-A925-1E75F60CD8B0

Q35681383-F8DDABB4-7AA0-4961-A71C-8C64359E40D4

P2860

Q35681383-004648ED-F1B5-4C1E-9548-9663B9038C66

Q35681383-0278C771-F15A-4D81-AE44-7D5A237DFD97

Q35681383-04C0E151-D3C2-417C-AC73-235B231C96A8

Q35681383-05EE9084-CA63-4275-975E-7F947705147E

Q35681383-065946F4-B650-4595-B072-7B8413488DEB

Q35681383-09980291-A28F-4500-B06B-8926C346989D

Q35681383-09A95E58-3F2F-4889-A1B7-A7CA3B423CEE

Q35681383-0C6BFB48-BD8C-45BF-9D1B-C0B9E02E5342

Q35681383-13F4B3CC-848D-4081-AEEE-5A482886288F

Q35681383-17E2DDDA-75B9-4EF8-9AFF-B27D053F63AB

P304

Q35681383-8609B7D0-E180-42BB-884D-ABE7787E3942

P31

Q35681383-EA028CF5-3216-4F41-AC12-4790CF81136F

P356

Q35681383-8C35F8AC-860B-4908-BE18-5FB107B3FF96

P433

Q35681383-37B10B81-A0D2-4724-A65B-A66715C76976

P478

Q35681383-3D6AD4DA-D0E9-4F33-BCBC-899AC7D505CE

P50

Q35681383-B2AB194C-CA53-4F8C-B342-444D96E1971D

P577

Q35681383-AABF01F6-29A8-4347-BDB0-B0EEBEAAEFEC

P5875

Q35681383-5AF16DCD-02C8-42E9-B0A1-0EA5B55732E7

P698

Q35681383-2D1A49AB-F692-4BAE-9CB4-A2DF66943844

P921

Q35681383-087D62E6-0BFE-4841-8739-8852E0354C29

Q35681383-acc4efdb-af0b-4804-81e4-8471a7f7de68

P932

Q35681383-14DBC8A9-750E-43A6-AA86-8F8FC535BB6E

P356

P1433

P1476

Therapeutic Developments Targeting Toll-like Receptor-4-Mediated Neuroinflammation

@en

P2093

Adam Csakai

http://www.w3.org/2001/XMLSchema#string

Fengchun Zhang

http://www.w3.org/2001/XMLSchema#string

Hang Yin

http://www.w3.org/2001/XMLSchema#string

Jialin Jin

http://www.w3.org/2001/XMLSchema#string

P2860

MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4

Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

A Toll-like receptor recognizes bacterial DNA

Discrimination of bacterial lipoproteins by Toll-like receptor 6

Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran

Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins

Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex

P304

154-165

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CMDC.201500188

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

279729357

http://www.w3.org/2001/XMLSchema#string

P698

26136385

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

4983275

http://www.w3.org/2001/XMLSchema#string